B.PolhemusD
As of 2022, GLP-1RAs have been recommended as first-line treatments, along with SGLT-2 inhibitors, for patients with T2DM and cardiovascular disease in American Diabetes Associations Standards of Medical Care in Diabetes (248, 249)
In addition to exosomes, it is rich in proteins and growth factors (cytokines) such as EGF, so it is expected to have anti-inflammatory, anti-allergic, wrinkle and blemish improvement, and other anti-aging effects
Researchers mix the powder with a sterile solution before testing
It inhibits hypoxia-driven fibroblast-to-myofibroblast transition, reducing abnormal electrical coupling (Schultz et al., 2016)
They may: Lower the dose Add mental health support Try a different medication Never stop a GLP-1 med on your own without medical advice